How many institutions own QCLS stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own QCLS shares is 21, representing 7.99% of the company's common stock.

Who are the major shareholders selling Q/C Technologies, Inc. stock?

QUINN OPPORTUNITY PARTNERS LLC, in the last quarter, reduced its stake in QCLS by -41.8% restricting it's holding to 123.02 thousand shares of worth nearly $479.79K. JANE STREET GROUP, LLC also lessened -30.86% of the QCLS shares from its portfolio, reducing its holding to 87.24 thousand shares of worth $340.24K. UBS GROUP AG also shunned QCLS shares holding by -24.48% last quarter which brought its holding to 58.89 thousand shares worth $229.69K.

Investors who are buying QCLS stock?

As per its latest 13F filing, VANGUARD CAPITAL MANAGEMENT LLC increased its stake in QCLS by 206.66% in the last quarter. The institutional holder raised its holding to 115.03 thousand shares having worth more than $448.62K. GEODE CAPITAL MANAGEMENT, LLC also added 49.15% more shares of QCLS to its portfolio, raising its holding to 70.68 thousand shares of worth $275.66K. BALYASNY ASSET MANAGEMENT L.P. also increased its QCLS shares holding by 100% which brought its holding to 57.69 thousand shares worth $225.00K.

QCLS's major insiders: who are they?

The insider with the most stakes in QCLS is PharmaCyte Biotech, Inc. , 10 percent owner at the company. Additionally, QCLS stock is highly held by director Voss Chelsea Sierra and N/A N/A among others.

Did an insider recently sell QCLS stock?

Company executives, directors, and other insiders own 7.85% percent of Q/C Technologies, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which QCLS insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

Which insider recently purchased QCLS stock?

There have been 1 transaction(s) during the past 6-months in which Q/C Technologies, Inc. insiders have bought stock, totalling 1753 shares

How much of QCLS does insiders own?

Around 61.56K Q/C Technologies, Inc. shares are held by insiders, which represents about 7.85% of QCLS stock.

Who is the insider with the largest stake?

QCLS 10 percent owner, PharmaCyte Biotech, Inc. holds the largest portfolio of the company's shares. QCLS shares owned by PharmaCyte total nearly 889.87 thousand.

Which institution holds the most shares in QCLS?

QUINN OPPORTUNITY PARTNERS LLC is the largest institutional owner in QCLS which holds 123.02 thousand shares worth $479.79K or 1.51% of the total QCLS shares outstanding followed by VANGUARD CAPITAL MANAGEMENT LLC with ownership of 115.03 thousand shares representing 1.41% of the QCLS ownership. JANE STREET GROUP, LLC is the third largest stakeholder with 87.24 thousand shares or 1.07% of the ownership worth more than $340.24K.

Is Q/C Technologies, Inc. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the QCLS is concerned, it is a stock which is not optionable.

Is there a short position on QCLS's shares?

Number of QCLS shares short is 1.50M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding QCLS shares are there?

As of today, 8.19M shares of QCLS are outstanding.

Is there many float in QCLS stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, QCLS has 8.11M shares in float.

QCLS short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for QCLS is 6.83.

Q/C Technologies (QCLS) insider trading activity: Get Latest News Today

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares19.09

Short Percent Of Float103.08

Shares Outstanding8.19M

Shares Float8.11M

Shares Short1.50M

Short Ratio6.83

103.08%

Short % of Float

19.09%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

7.85% Percentage of Shares held by All Insiders

7.99% Percentage of Shares held by All Institutions

8.68% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 7.99% of QCLS shares are held by financial institutions. QUINN OPPORTUNITY PARTNERS LLC is the top corporate investor, holding 123.02K shares valued at $479.79K. A 1.51% stake in Q/C Technologies, Inc. is owned by the company. VANGUARD CAPITAL MANAGEMENT LLC owns 115.03K shares valued at $448.62K, which translates its holding of 1.41% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Jun 30, 2026	QUINN OPPORTUNITY PARTNERS LLC	1.51%	123.02K	479.79K	-88.37K	-41.80%
Jun 30, 2026	VANGUARD CAPITAL MANAGEMENT LLC	1.41%	115.03K	448.62K	77.52K	+206.66%
Jun 30, 2026	JANE STREET GROUP, LLC	1.07%	87.24K	340.24K	-38.95K	-30.86%
Jun 30, 2026	GEODE CAPITAL MANAGEMENT, LLC	0.87%	70.68K	275.66K	23.29K	+49.15%
Jun 30, 2026	UBS GROUP AG	0.72%	58.89K	229.69K	-19.1K	-24.48%
Jun 30, 2026	BALYASNY ASSET MANAGEMENT L.P.	0.71%	57.69K	225K	57.69K	+100.00%
Jun 30, 2026	HRT FINANCIAL LP	0.62%	50.37K	196K	27.97K	+124.84%
Jun 30, 2026	ADAR1 CAPITAL MANAGEMENT, LLC	0.61%	50K	195K	0	0
Jun 30, 2026	VANGUARD FIDUCIARY TRUST CO	0.53%	43.05K	167.91K	27.5K	+176.78%
Jun 30, 2026	STATE STREET CORP	0.31%	25.31K	98.69K	12.4K	+96.09%
Jun 30, 2026	DIMENSIONAL FUND ADVISORS LP	0.23%	19.06K	74.33K	0	0
Jun 30, 2026	NORTHERN TRUST CORP	0.22%	18K	70.19K	18K	+100.00%
Jun 30, 2026	PEAK6 LLC	0.16%	12.78K	49.83K	12.78K	+100.00%
Jun 30, 2026	PIN OAK INVESTMENT ADVISORS INC	0.04%	3.5K	14K	0	0
Jun 30, 2026	TOWER RESEARCH CAPITAL LLC (TRC)	0.01%	1.04K	4.07K	-550	-34.53%
Jun 30, 2026	BARCLAYS PLC	0.01%	950	3.71K	950	+100.00%
Jun 30, 2026	SBI SECURITIES CO., LTD.	0%	100	390	100	+100.00%
Jun 30, 2026	BLACKROCK, INC.	0%	19	74	0	0
Jun 30, 2026	CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD	0%	9	35	9	+100.00%
Jun 30, 2026	JONES FINANCIAL COMPANIES LLLP	0%	2	7	0	0
Jun 30, 2026	BRYN MAWR TRUST CO	0%	1	4	0	0
Jun 30, 2026	BNP PARIBAS ARBITRAGE, SNC	0%	0	-	-300	-100.00%
Mar 31, 2026	ADAR1 CAPITAL MANAGEMENT, LLC	0.62%	50K	172.5K	50K	+100.00%
Mar 31, 2026	VANGUARD CAPITAL MANAGEMENT LLC	0.47%	37.51K	129.41K	37.51K	+100.00%
Mar 31, 2026	DIMENSIONAL FUND ADVISORS LP	0.24%	19.06K	65.75K	0	0
Mar 31, 2026	GEODE CAPITAL MANAGEMENT, LLC	0.59%	47.39K	163.5K	18.14K	+62.01%
Mar 31, 2026	QUINN OPPORTUNITY PARTNERS LLC	2.62%	211.39K	729.3K	0	0
Mar 31, 2026	JANE STREET GROUP, LLC	1.57%	126.19K	435.35K	85.7K	+211.68%
Mar 31, 2026	UBS GROUP AG	0.97%	77.99K	269.06K	60.56K	+347.57%
Mar 31, 2026	HRT FINANCIAL LP	0.28%	22.4K	77K	22.4K	+100.00%
Mar 31, 2026		0.47%	37.51K	129.41K	37.51K	+100.00%
Mar 31, 2026	BANK OF AMERICA CORP /DE/	0%	0	-	-25	-100.00%
Mar 31, 2026	WELLS FARGO & COMPANY/MN	0%	0	-	-1	-100.00%
Mar 31, 2026	MORGAN STANLEY	0%	0	-	-20	-100.00%
Mar 31, 2026	VANGUARD FIDUCIARY TRUST CO	0.19%	15.56K	53.67K	15.56K	+100.00%
Mar 31, 2026	STATE STREET CORP	0.16%	12.91K	44.52K	12.91K	+100.00%
Mar 31, 2026	PIN OAK INVESTMENT ADVISORS INC	0.04%	3.5K	12K	3.5K	+100.00%
Mar 31, 2026	SUNBELT SECURITIES, INC.	0.02%	1.75K	6.04K	1.75K	+100.00%
Mar 31, 2026	VIRTU FINANCIAL LLC	0%	0	-	-35.38K	-100.00%
Mar 31, 2026	PRIVATE ADVISOR GROUP, LLC	0%	0	-	-333.83K	-100.00%
Mar 31, 2026	ENGINEERS GATE MANAGER LP	0%	0	-	-11.33K	-100.00%
Mar 31, 2026	BRYN MAWR TRUST CO	0%	1	3	0	0
Mar 31, 2026	GROUP ONE TRADING, L.P.	0%	0	-	-2	-100.00%
Mar 31, 2026	TOWER RESEARCH CAPITAL LLC (TRC)	0.02%	1.59K	5.5K	1.36K	+577.87%
Mar 31, 2026	BNP PARIBAS ARBITRAGE, SNC	0%	300	1.04K	-900	-75.00%
Mar 31, 2026	BLACKROCK, INC.	0%	19	66	0	0
Mar 31, 2026	JONES FINANCIAL COMPANIES LLLP	0%	2	7	0	0

Insiders

Among the QCLS insiders holding of 7.85% of the stake in company, PHARMACYTE BIOTECH, INC., 10 percent owner, holds the largest shares of 889.87K. VOSS CHELSEA SIERRA, director, is the second largest QCLS insider with ownership of 61.56K shares. , , stands third with possession of - shares of that stake.

Insiders	Designation	Shares Held
PHARMACYTE BIOTECH, INC.	10 percent owner	889.87K
VOSS CHELSEA SIERRA	director	61.56K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Mar 30, 2026	VOSS CHELSEA SIERRA	PURCHASE	3.15	1.75K	5.52K	61.56K
Nov 14, 2025	PHARMACYTE BIOTECH, INC.	PURCHASE	0.00	889.87K	-	889.87K
Sep 04, 2025	PHARMACYTE BIOTECH, INC.	PURCHASE	0.00	889.87K	-	889.87K

Insider Transaction Summary (6 Months)

SHARESTRANS

PURCHASE1.75K1

SALES00

NET SHARES1.75K1

SHARES HELD61.56K1

% NET SHARES-97.15%0%

QCLS Stock Ownership Breakdown

Q/C Technologies

Stock Outstanding Shares

Market Insider

Institutional Ownership

Insiders

Buying/Selling by Insiders

Insider Transaction Summary (6 Months)

Frequently Asked Questions

Stock Outstanding Shares

Market Insider

Institutional Ownership

Insiders

Buying/Selling by Insiders

Insider Transaction Summary (6 Months)

Frequently Asked Questions